Press release titled " Stallion India Fluorochemicals Reports Strong Q1 FY27 Performance; PAT Surges 79% YoY to Rs. 18.59 Crore"

Date: 12th August, 2026 To, To, National Stock Exchange of India Limited BSE Limited (“BSE”), (“NSE”), The Listing Department Corporate Relationship Department, Exchange Plaza, 5th Floor, 2nd Floor, New Trading Ring, Plot No. C/1, G Block, Bandra-Kurla Complex P.J. Towers, Dalal Street, Bandra (East), Mumbai – 400 051. Mumbai – 400 001. NSE Symbol: STALLION BSE Scrip Code: 544342 ISIN: INE0RYC01010 ISIN: INE0RYC01010 Sub: Press Release Dear Sir/Madam, Please find enclosed the press release titled “Stallion India Fluorochemicals Reports Strong Q1 FY27 Performance; PAT Surges 79% YoY to ₹18.57 Crore” We request you to kindly take the above on record and acknowledge receipt. Yours Faithfully, For Stallion India Fluorochemicals Limited Govind Rao Company Secretary & Compliance Officer Stallion India Fluorochemicals Reports Strong Q1 FY27 Performance; PAT Surges 79% YoY to ₹18.57 Crore Mumbai, 12th August 2026 - Stallion India Fluorochemicals Limited (SIFL), a leading forward integrated player in refrigeration and industrial gas operates as a critical link in the industrial gas supply chain, focusing on processing, blending, and distributing specialized gases across multiple sectors, has announced its unaudited financial results for the Q1 FY26-27. Key Financial Highlights: Q1 FY25-26 Q1 FY26-27 (In ₹ Lakhs ) Particulars (₹ Lakhs) Q1 FY25-26 Q1 FY26-27 YoY Change Total Revenue 11,054.55 12,467.57 12.78% EBITDA 1,436.94 2,526.79 75.85% PBT 1,386.14 2,478.88 78.83% PAT 1,036.32 1,856.58 79.15% 55.450,11 75.764,21 TOTAL REVENUE 49.634,1 97.625,2 EBITDA 23.630,1 85.658,1 Key Operational Highlights:  A key milestone during the period was the completion of preparations for high-purity helium processing at the Company's Khalapur facility, which has an installed capacity of 1,200 MT per annum. Commercial operations are expected to commence in the upcoming quarter.  The Company's upcoming facility at Mambattu, Andhra Pradesh, is progressing as planned and is expected to commence operations between November and December 2026.  Stallion continues to advance the development of its 10,000 MT per annum R-32 manufacturing facility at Bhilwara, Rajasthan. Industry Outlook:  The global fluorochemicals market is projected to grow from USD 76.7 billion in 2025 to USD 204.4 billion by 2035, at a CAGR of 10.3%, driven by demand from refrigeration, electronics, pharmaceuticals and automotive applications.  India's fluorochemicals market, valued at approximately USD 750 million in 2025, is expected to grow at around 10.5% CAGR during 2026–34, supported by industrial expansion and increasing adoption of low-GWP refrigerants such as R-32 and HFOs.  India's air-conditioning market is projected to grow at 14.98% CAGR, while the semiconductor industry is expected to grow at 11.95% CAGR, creating opportunities for refrigerants, specialty gases and semiconductor-related gases.  Environmental regulations, sustainability initiatives and government-led manufacturing programmes are supporting the transition towards low-GWP refrigerants, HFOs and specialty gases, while creating opportunities across semiconductors, electronics, solar cells, healthcare and advanced industries. Management Commentary Mr. Shazad Sheriar Rustomji - Managing Director & CEO of Stallion India Fluorochemicals Limited, commented on the company's results: " We have commenced FY27 with strong operational and financial momentum. During Q1 FY27, total revenue grew 12.78% YoY to ₹124.68 crore, while EBITDA increased 75.85% to ₹25.27 crore and PAT grew 79.15% to ₹18.57 crore, reflecting a meaningful improvement in profitability. Our growth strategy remains focused on scaling higher-value products and strengthening backward integration. Our Khalapur facility for high-purity helium processing, with an installed capacity of 1,200 MT per annum, has been completed, with commercial operations expected to commence in the upcoming quarter, catering to applications across semiconductors, electronics, healthcare, aerospace and defence. Given the critical and scarce nature of helium, we are also working with ISRO on long-term Helium Recovery and Liquefaction solutions for space applications and have participated in a large tender floated by ISRO for such systems. The Mambattu facility is progressing as planned and is expected to commence operations by the end of Q3 FY27, while our 10,000 MT R-32 manufacturing facility at Bhilwara is progressing towards completion, targeted for completion by the end of December 2026. We remain confident of delivering 30–35% revenue CAGR over the next three years, with backward integration and higher-value specialty gases expected to improve EBITDA margins by approximately 3–4% over the medium term. With these initiatives, we remain focused on disciplined execution, portfolio diversification and building a stronger, more integrated fluorochemicals and specialty gases platform.” About Stallion India Fluorochemicals Limited Incorporated in 1992, Stallion India Fluorochemicals Limited stands as a specialized leader in the refrigerants and industrial gases sector. With over three decades of experience, the company has established itself as a key player in processing, blending, and distributing gases across diverse industries including air conditioning, refrigeration, fire-fighting, semiconductor manufacturing, pharmaceuticals, automotive, and glass production. The company operates four strategic manufacturing facilities located in Khalapur, Ghiloth, Manesar, and Panvel, specializing in the debulking, blending, and processing of gases. SIFL's unique positioning lies in its focus on gas blending, differentiating it from competitors who primarily manufacture base molecules. The company serves a wide range of industries by providing tailored gas solutions, including Hydrocarbons (HC), Hydrofluorocarbons (HFCs), and Hydrofluoroolefins (HFOs). SIFL has consistently demonstrated a commitment to safety, innovation, and environmental responsibility. Disclaimer This document contains forward-looking statements, which are not historical facts and are subject to risks and uncertainties such as government actions, local developments, and technological risks. The Company is not responsible for any actions taken based on these statements and does not commit to publicly updating them to reflect future events or circumstances. For Further Information Please Contact ConfideLeap Partners info@confideleap.com +(91) 85911 45959 www.confideleap.com